A Case of Hemorrhagic Cholecystitis in a Patient on Apixaban After COVID-19 Infection

Zohour Anouassi; Carlos Abril; Ghanem Ismail; Wasim S. El Nekidy; Abdullah Al-Hadeethi; Ahmed Bafadel; Bassam Atallah

doi:10.12659/AJCR.939677

21 July 2023 : Case report United Arab Emirates

A Case of Hemorrhagic Cholecystitis in a Patient on Apixaban After COVID-19 Infection

Unknown etiology, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Adverse events of drug therapy

Zohour Anouassi

^1ABEF, Carlos Abril^2ABEF, Ghanem Ismail^3ABEF, Wasim S. El Nekidy

^14ABEF, Abdullah Al-Hadeethi^3ABEF, Ahmed Bafadel^3ABEF, Bassam Atallah^14ABEF*

DOI: 10.12659/AJCR.939677

Am J Case Rep 2023; 24:e939677

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 3. Axial T2-weighted image from non-contrast MRI abdomen shows distended gall bladder by intraluminal mildly hyperintense material (arrowed) and thickened bright wall.

Back to the Article

A Case of Hemorrhagic Cholecystitis in a Patient on Apixaban After COVID-19 Infection

Your Privacy